Dr Jenny Hill

Senior Programme Manager

Jenny Hill is a public health epidemiologist with an MSc in Medical Parasitology from the London School of Hygiene & Tropical Medicine and a PhD on the delivery, access and use of interventions to control malaria in pregnancy in sub-Saharan Africa from the University of Amsterdam. In her early career she worked for UNICEF over a period of seven years to develop community-based malaria control programmes as part of broader child survival programmes in Kenya, Uganda, Zambia, northern Namibia and Botswana. She joined LSTM in 1995, previously as Deputy Director of the DFID-funded Malaria Consortium (to 2004) and then as Project Manager of the Gates-funded MiP Consortium and also Principle Investigator leading the Public Health Impact theme (to 2016). She is currently Senior Programme Manager in the Malaria Epidemiology unit lead by Professor Feiko ter Kuile, managing a portfolio of grants including the IMPROVE trials co-funded by EDCTP and MRC/DFID/WT Joint Global Health Trials Scheme. She currently holds research grants from EDCTP (IMPPACT project), WWARN/Oxford (MiP Scientific Group) and PATH.

Research
Research interests focus on strategies for optimizing the delivery of malaria control interventions which target vulnerable groups - in particular pregnant women and young children – involving integrated approaches to service delivery. Current projects include policy research on the translation of research evidence generated by the Malaria in Pregnancy Consortium into policy and practice (IMPPACT project); acceptability, feasibility and cost effectiveness studies of new strategies to prevent malaria in pregnancy in Kenya, Malawi, and Tanzania as part of the IMPROVE trials; and a longitudinal study to document and explore the dynamics of the implementation of the world’s first malaria vaccine, RTS,S/AS01 in western Kenya (Kenya HUS study).

Memberships 

Member of the Roll Back Malaria Working Group on Malaria in Pregnancy (2006-present)

Member of the Roll Back Malaria Working Group on Insecticide treated nets (1999-present)

Current research grants:

The Dynamics of Healthcare Utilization in the Context of RTS,S/AS01 Vaccine Introduction in Kenya (HUS), PATH Seattle (01/02/2018-30/06/2021). Principal Investigator.

Malaria in Pregnancy Scientific Group, World-wide Antimalarial Resistance Network (WWARN), Oxford (01/09/2017-31/08/2020). Principle Investigator.

Maximising the public health impact of interventions to control malaria in pregnancy through the translation of EDCTP-funded evidence-based global policies to country level policies and plans

EDCTP (01/012016-31/12/2018). Principal Investigator.

IPTp with dihydroartemisinin-piperaquine and azithromycin for malaria, sexually transmitted and reproductive tract infections in HIV-infected pregnant women in Kenya and Malawi: a multi-centre 3-arm placebo-controlled trial (IMPROVE-2). EDCTP/MRC/DFID/WT (01/07/2017-30/11/2020).  Co-Investigator & Principle Investigator of sub-studies on Acceptability, feasibility and cost effectiveness.

Intermittent preventive therapy (IPTp) with dihydroartemisinin-piperaquine and azithromycin for malaria, sexually transmitted and reproductive tract infections in pregnancy in high sulphadoxine-pyrimethamine resistance areas in Kenya, Malawi, and Tanzania (IMPROVE). EDCTP (1/12/2016-30/11/2020). Co-Investigator & Principle Investigator of sub-studies on Acceptability, feasibility and cost effectiveness.

Selected publications

    1. Webster J, Ansariadi, Burdam FH, Landuwulang CUR, Bruce J, Poespoprodjo JR, Syafruddin D, Ahmed R, Hill J. Evaluation of the implementation of single screening and treatment for the control of malaria in pregnancy in Eastern Indonesia: a systems effectiveness analysis. Malaria Journal. 2018;17(1):310.
    2. Hoyt J, Landuwulang CUR, Ansariadi, Ahmed R, Burdam FH, Bonsapia I, Poespoprodjo JR, Syafruddin D, Ter Kuile FO, Webster J, Hill J. Intermittent screening and treatment or intermittent preventive treatment compared to current policy of single screening and treatment for the prevention of malaria in pregnancy in Eastern Indonesia: acceptability among health providers and pregnant women. Malaria Journal. 2018;17(1):341.
    3. Hill J, Landuwulang CUR, Ansariadi, Hoyt J, Burdam FH, Bonsapia I, et al. Evaluation of the national policy of single screening and treatment for the prevention of malaria in pregnancy in two districts in Eastern Indonesia: health provider perceptions. Malaria Journal. 2018;17(1):309.
    4. D’Alessandro U, Hill J, Tarning J, Pell C, Webster J, Gutman J, Sevene E. Treatment of uncomplicated and severe malaria during pregnancy. Lancet ID 2018; 18:4.
    5. Desai M, Hill J, Fernandes S, Walker P, Pell C, Gutman J, Kayentao K, Gonzalez R, Webster J, Greenwood B, Cot M, ter Kuile FO. Prevention of malaria in pregnancy: a systematic review and meta-analysis. Lancet ID 2018: 18:4.
    6. Young N, Taegtmeyer M, Aol G, Bigogo GM, Phillips-Howard PA, Hill J, Laserson KF, Ter Kuile F, Desai M. Integrated point-of-care testing (POCT) of HIV, syphilis, malaria and anaemia in antenatal clinics in western Kenya: A longitudinal implementation study. PLoS One 2018; 13(7): e0198784.
    7. Hill J, Kuile FO. Dihydroartemisinin-piperaquine holds promise as an option for malaria prevention in pregnancy. Evidence Based Med. 2016;21(4):146-7.
    8. Tesfazghi K, Traore A, Ranson H, N'Fale S, Hill J and Worrall E. Challenges and opportunities associated with the introduction of next-generation long-lasting insecticidal nets for malaria control: a case study from Burkina Faso. Implement Sci. 2016;11:103.
    9. Tesfazghi K, Hill J, Jones C, Ranson H, Worrall E. National malaria vector control policy: an analysis of the decision to scale-up larviciding in Nigeria. Health Policy and Planning. 2016;31(1):91-101.
    10. Hill J, Hoyt J, Achieng F, Ouma P, L'Lanziva A, Kariuki S, et al. User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya. PloS one. 2016;11(3):e0150259.
    11. Dellicour S, Hill J, Bruce J, Ouma P, Marwanga D, Otieno P, et al. Effectiveness of the delivery of interventions to prevent malaria in pregnancy in Kenya. Malar J. 2016;15(1):221.
    12. Burger RJ, van Eijk AM, Bussink M, Hill J, Ter Kuile FO. Artemisinin-Based Combination Therapy Versus Quinine or Other Combinations for Treatment of Uncomplicated Plasmodium falciparum Malaria in the Second and Third Trimester of Pregnancy: A Systematic Review and Meta-Analysis. Open Forum Infect Dis. 2016;3(1):ofv170.

    Peer Reviewed reports

    Jenny Hill and Annemieke van Eijk, for the Roll Back Malaria Partnership, 2014. "Progress and Impact Series 10: The Contribution of Malaria Control to Maternal and Newborn Health." Geneva: World Health Organisation. http://www.rollbackmalaria.org/multimedia/progress-and-impact-series.html